Congenital tuberculosis (CTB) due to maternal genitourinary (GU) TB infection is a rare occurrence, as infection of the genital tract in women generally leads to infertility. Increasing availability of assisted reproductive technology creates the potential for CTB to emerge as a significant problem. We describe five infants (two sets of twins and a singleton birth) conceived by in vitro fertilization who developed CTB. All five infants were born to mothers who had immigrated to the United States from India and none had GU TB diagnosed before the birth of their infected infants.
INTRODUCTION
Congenital tuberculosis (CTB) is rarely seen, with only several hundred cases reported in the literature. 1 Even in TB-endemic countries, CTB is rare because chronic genitourinary (GU) TB causes infertility. 2 However, the increased availability of assisted reproductive technology allows emergence of CTB if mothers are not properly evaluated and treated before implantation of embryos. Furthermore, early diagnosis of tuberculosis in neonates is difficult and delayed recognition of the disease can be detrimental. In this case series, we describe five infants with CTB: three infants with culture-proven TB, one confirmed by tuberculin skin test (TST) and one with presumed TB, after conception by in vitro fertilization (IVF).
CASES
All five neonates were conceived by IVF and delivered in three different hospitals in New Jersey to mothers who immigrated to the United States from different regions of India. Case details are summarized in Table 1 .
Cases one and two Cases one and two were twins who presented in 2011 after birth at 31 weeks' gestation via primary cesarean delivery for premature preterm rupture of membranes and chorioamnionitis. Maternal history included chronic ascites and a supraclavicular cold abscess in 2004 that was suspicious for TB, for which she had declined biopsy and treatment. At the time, paracentesis was consistent with an inflammatory reaction and TST was negative. TB evaluation was not repeated before IVF.
The infants' initial course was unremarkable. On day of life (DOL) 19, twin A developed apnea and bradycardia, prompting an evaluation for serious bacterial infection, which included blood, urine and cerebrospinal fluid cultures, and empiric treatment. Cultures were negative. However, he developed progressive respiratory failure and septic shock and was transferred to a quaternary-care facility.
It was noted at transfer that the mother had persistent fever and chills, despite treatment for chorioamnionitis and nosocomial pneumonia. An expanded diagnostic evaluation included a TST and an interferon gamma release assay. Both were positive. After these maternal results, gastric aspirate and tracheal aspirates were obtained from the infant for acid-fast bacillus (AFB) staining and culture and therapy with intravenous rifampin, amikacin, linezolid and ciprofloxacin was started to treat presumptive CTB.
Despite treatment, the infant's condition declined and the family withdrew support on DOL 33. Post-mortem examination revealed multiple subpleural nodules (B1 mm) and direct smear revealed AFB. Culture subsequently grew Mycobacterium africanum.
On the day twin A expired, twin B began having apnea and bradycardia and radiographic evidence of pneumonia. Cultures were taken from her blood, urine and cerebrospinal fluid and empiric antibiotic therapy was started, including anti-tuberculous therapy. A TST at that time was negative. Gastric aspirates were AFB negative. Within 2 days of starting TB therapy, the infant had weaned from respiratory support. At 4 months of age, her TST was 9 mm and the chest X-ray showed resolution of the previously seen opacity. She continued to thrive with no persistent respiratory issues, so therapy was stopped after 9 months.
Postnatal re-evaluation of the mother included a TST that was positive (15 mm), a positive interferon gamma release assay and an endometrial biopsy that was negative for granulomas or AFB, but culture grew M. africanum with identical genotype to twin A's isolate (Supplementary Figure and Table 2 ).
Case three Case three was born vaginally in 2007 at 32 weeks' gestation. His mother had no history of TB and testing was not performed before IVF. The infant developed respiratory insufficiency on DOL 24, which progressed to respiratory failure over the next 12 days Table 2 ).
Cases four and five Cases four and five were twins born in 2007 at 35 weeks' gestation via cesarean delivery due to maternal pre-eclampsia. Maternal hysterosalpingogram before IVF implantation revealed bilateral occlusion of the fallopian tubes and her TST was positive. No treatment was prescribed for the positive TST. When she later presented with hypertension, she was re-evaluated for TB with chest computed tomography that showed calcified nodules and hilar lymph nodes. This was interpreted as a past infection and no further evaluation was performed or treatment prescribed. Delivery and immediate postnatal course were uneventful and the infants were discharged home. The mother's postpartum course was complicated by three episodes of uterine bleeding. Endometrial curettings revealed granulomas with rare AFB. The infants were re-evaluated at this time and found to have mild respiratory insufficiency with chest radiograph findings noted in Table 1 . Both were evaluated with blood, cerebrospinal fluid cultures and gastric aspirates and started on anti-tuberculous therapy. Gastric aspirate from twin A was positive for MTB by culture (Supplementary Figure and Table 2 ). Both twins struggled with hypoxemia and failure to thrive. They required feeding supplements and did not begin catch-up growth until 6 months of age. However, by 12 months of age, both children had normal chest radiographs and were doing well.
DISCUSSION
These five neonates (four confirmed, one presumptive) are the first reported cases of IVF-related CTB in the United States. To date, there have been six other cases of IVF-related CTB reported outside of the United States. [3] [4] [5] [6] [7] These previous cases share many similarities with ours. Three of the mothers immigrated to and received IVF in a TB non-endemic country. 3, 4, 6 None of the mothers was evaluated prenatally for TB, and all received diagnoses of GU TB after their infants became ill. All six infants were born prematurely, were initially well appearing and presented with respiratory insufficiency and sepsis. Two of these previous infants had additional findings of skin macules and nodules, 3, 5 which were not seen in our cases. GU TB occurs through hematogenous spread and pelvic organs are involved at varying rates. 8 In TB-endemic countries, GU TB is a common cause of infertility, implicated in 2 to 21% of infertile women. 2, [9] [10] [11] [12] More recent studies using molecular diagnostic techniques and multiple samples reveal a higher burden, with 56 to 78% of infertile women in India having MTB-positive endometrial tissue and menstrual blood. 13, 14 These results suggest that rates of GU TB are grossly underestimated.
Infants with CTB present with non-specific respiratory and systemic symptoms, typically at 2 to 4 weeks of life. 1, 15 Diagnosis is largely dependent on a thorough review of history and risk factors. Even with the recommended treatment using four antituberculous drugs, mortality is elevated, 1 and survival may be dependent on time to diagnosis and initiation of appropriate therapy.
Because GU TB causes infertility, rates of CTB have been low. However, as illustrated in this case series, CTB can occur after IVF in high-risk women in TB non-endemic regions. Currently, TB testing is not included in the standard diagnostic evaluation of infertile females, 16 and it is not included in the Food and Drug Administration-mandated testing for donors of human cells and tissues, which applies to reproductive tissue donation. 17 However, this case series highlights first that physicians in the reproductive community should perform TB testing in infertile women with risk factors. Multiple diagnostic modalities, including TST, interferon gamma release assay, imaging and endometrial biopsy with AFB smear and culture should be used. Second, neonatologists and pediatricians should maintain a high index of suspicion for CTB in infants with progressive, unexplained respiratory illness who were conceived by IVF in mothers with TB risk factors. In this table, results of three independent molecular-typing techniques are presented. In each mother-child dyad with isolated cultures, molecular typing was performed on the isolate from the mother and the isolate from the infant and then compared. In all cases, the three independent techniques uniquely identified the isolate in the infant as being identical to the isolate in the mother, confirming mother-to-child transmission. Subject identifications correspond to Table 1 and lanes in Supplementary Figure. Methods previously published 18 were used to generate these data.
